Biosplice Therapeutics: Troy Cox, Karen McGinnis

Troy Cox and Karen McGinnis have joined the board of directors of Biosplice Therapeutics.

Cox is the former CEO of Foundation Medicine. Prior to that, he was senior VP and an officer at Genentech, and before that, he was president of UCB BioPharmaceuticals, senior VP of Sanofi-Aventis, and held several roles at Schering-Plough.

McGinnis most recently served as VP and chief accounting officer at Illumina. Before that, she was director, president, and CEO of Mad Catz Interactive.